MetLife (MET) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $2.43
- Estimate
- $2.29
- Surprise
- +6.2%
- Score today
- 5.2/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
MetLife (MET) beat the $2.29 estimate with adjusted EPS of $2.43 — a clear 6.2% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates MET Sell at 5.2/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +6.2% surprise compares with a +5.3% four-quarter average. Next scheduled report: 2026-11-04.
What argues against it
- Target reached (-4.1% upside)
- Quality below floor (3.4 < 4.0)
- Negative risk/reward — downside exceeds upside
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $100.65
- Price target
- $115.75
- Stop
- $96.69
- Upside to target
- +15.0%
The stock trades at 19.3× trailing but 9.0× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-14 — shown for context, not personalized investment advice.
MET at TrendMatrix's latest read
For financials, the EPS print is only half the story: credit costs, reserve builds, and rate sensitivity decide how a quarter actually lands.
- Industry
- Insurance - Life
- Market cap
- $63.96B
- P/E (fwd)
- 9.0
- P/E (ttm)
- 19.3
- 52-week range
- $67.33–$101.43
- Off 52-week high
- 0.8%
- RSI (14)
- 63
- Volume vs avg
- 0.91×
- Score today
- 5.2/10